Cerebrosterol

Cerebrosterol is a lipid of Sterol Lipids (ST) class. Cerebrosterol is associated with abnormalities such as nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Senile Plaques and Hypercholesterolemia. The involved functions are known as Blood - brain barrier function, Oxidation, 5-(carboxyamino)imidazole ribonucleotide mutase activity, cholesterol biosynthetic process and Anabolism. Cerebrosterol often locates in Hepatic, Body tissue, Autosome, brain tissue surgical material and Tissue membrane. The associated genes with Cerebrosterol are CYP27A1 gene, Alleles, INS gene, Apolipoprotein E4 and PLXNB1 gene. The related lipids are Sterols, 7-dehydrocholesterol, 27-hydroxycholesterol, 24-hydroxycholesterol and Dehydrocholesterols. The related experimental models are Mouse Model.

Cross Reference

Introduction

To understand associated biological information of Cerebrosterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Cerebrosterol?

Cerebrosterol is suspected in Hypercholesterolemia, nervous system disorder, Neurodegenerative Disorders, Alzheimer's Disease, Primary open angle glaucoma, Hypertensive disease and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Cerebrosterol

MeSH term MeSH ID Detail
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Nerve Degeneration D009410 53 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with Cerebrosterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Cerebrosterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Cerebrosterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Cerebrosterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Cerebrosterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Cerebrosterol?

Mouse Model

Mouse Model are used in the study 'Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation.' (Valenza M et al., 2007).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Cerebrosterol

Download all related citations
Per page 10 20 50 100 | Total 193
Authors Title Published Journal PubMed Link
Weiner MF et al. Plasma 24S-hydroxycholesterol and other oxysterols in acute closed head injury. 2008 Brain Inj pmid:18568715
Bang HJ et al. A comparison of the potential unfavorable effects of oxycholesterol and oxyphytosterol in mice: different effects, on cerebral 24S-hydroxychoelsterol and serum triacylglycerols levels. 2008 Biosci. Biotechnol. Biochem. pmid:19060413
Khripach VA et al. [A new synthesis of cerebrosterol and its 24-epimer from lithocholic acid]. 2007 Mar-Apr Bioorg. Khim. pmid:17476989
Chen W et al. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. 2007 Cell Metab. pmid:17189208
Karu K et al. Liquid chromatography-mass spectrometry utilizing multi-stage fragmentation for the identification of oxysterols. 2007 J. Lipid Res. pmid:17251593
Fujiyoshi M et al. 24S-hydroxycholesterol induces cholesterol release from choroid plexus epithelial cells in an apical- and apoE isoform-dependent manner concomitantly with the induction of ABCA1 and ABCG1 expression. 2007 J. Neurochem. pmid:17101031
Shafaati M et al. Levels of ApoE in cerebrospinal fluid are correlated with Tau and 24S-hydroxycholesterol in patients with cognitive disorders. 2007 Neurosci. Lett. pmid:17822846
Björkhem I Rediscovery of cerebrosterol. 2007 Lipids pmid:17393206
Valenza M et al. Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation. 2007 Hum. Mol. Genet. pmid:17613541
Teunissen CE et al. 24S-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. 2007 J. Neurosci. Res. pmid:17410599
Hansson M et al. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase. 2007 J. Intern. Med. pmid:17444890
Ohtsuki S et al. Brain-to-blood elimination of 24S-hydroxycholesterol from rat brain is mediated by organic anion transporting polypeptide 2 (oatp2) at the blood-brain barrier. 2007 J. Neurochem. pmid:17868302
Burkard I et al. Lipoprotein distribution and biological variation of 24S- and 27-hydroxycholesterol in healthy volunteers. 2007 Atherosclerosis pmid:17107679
Famer D et al. Regulation of alpha- and beta-secretase activity by oxysterols: cerebrosterol stimulates processing of APP via the alpha-secretase pathway. 2007 Biochem. Biophys. Res. Commun. pmid:17532301
Joffre C et al. Oxysterols induced inflammation and oxidation in primary porcine retinal pigment epithelial cells. 2007 Curr. Eye Res. pmid:17453947
Umetani M et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. 2007 Nat. Med. pmid:17873880
Leoni V et al. Are the CSF levels of 24S-hydroxycholesterol a sensitive biomarker for mild cognitive impairment? 2006 Apr 10-17 Neurosci. Lett. pmid:16406316
Kölsch H et al. Polymorphism in ABCA1 influences CSF 24S-hydroxycholesterol levels but is not a major risk factor of Alzheimer's disease. 2006 Int. J. Mol. Med. pmid:16596262
Björkhem I Crossing the barrier: oxysterols as cholesterol transporters and metabolic modulators in the brain. 2006 J. Intern. Med. pmid:17116000
Lukiw WJ Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease. 2006 Expert Rev Neurother pmid:16734516
Lütjohann D Cholesterol metabolism in the brain: importance of 24S-hydroxylation. 2006 Acta Neurol. Scand., Suppl.c pmid:16866909
Abildayeva K et al. 24(S)-hydroxycholesterol participates in a liver X receptor-controlled pathway in astrocytes that regulates apolipoprotein E-mediated cholesterol efflux. 2006 J. Biol. Chem. pmid:16524875
Thelen KM et al. High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. 2006 J Clin Pharmacol pmid:16809807
Panzenboeck U et al. Regulatory effects of synthetic liver X receptor- and peroxisome-proliferator activated receptor agonists on sterol transport pathways in polarized cerebrovascular endothelial cells. 2006 Int. J. Biochem. Cell Biol. pmid:16530456
Solfrizzi V et al. Circulating biomarkers of cognitive decline and dementia. 2006 Clin. Chim. Acta pmid:16139826
Kölsch H et al. Polymorphism in neuropeptide Y influences CSF cholesterol levels but is no major risk factor of Alzheimer's disease. 2006 J Neural Transm pmid:15959845
Björkhem I et al. Oxysterols and Alzheimer's disease. 2006 Acta Neurol. Scand., Suppl.c pmid:16866910
Karrenbauer VD et al. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. 2006 Clin Neurol Neurosurg pmid:16144738
Thelen KM et al. Effect of pravastatin on plasma sterols and oxysterols in men. 2006 Eur. J. Clin. Pharmacol. pmid:16385401
He X et al. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. 2006 J. Neuropathol. Exp. Neurol. pmid:16825952
Vogelvang TE et al. Effect of raloxifene and hormone therapy on serum markers of brain and whole-body cholesterol metabolism in postmenopausal women. 2005 Maturitas pmid:15780532
Papassotiropoulos A et al. A cluster of cholesterol-related genes confers susceptibility for Alzheimer's disease. 2005 J Clin Psychiatry pmid:16013913
Alexandrov P et al. 24S-hydroxycholesterol induces inflammatory gene expression in primary human neural cells. 2005 Neuroreport pmid:15931060
Teunissen CE et al. Biological markers in CSF and blood for axonal degeneration in multiple sclerosis. 2005 Lancet Neurol pmid:15620855
Sauder S et al. Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients. 2005 J Neural Transm pmid:15666037
Sovic A et al. Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrier. 2005 J. Neurochem. pmid:15953354
Holdenrieder S et al. Does brain specific 24S-hydroxycholesterol in plasma indicate the disruption of the blood-brain barrier in patients with ischemic stroke? 2004 Neurosci. Lett. pmid:15351449
Björkhem I and Meaney S Brain cholesterol: long secret life behind a barrier. 2004 Arterioscler. Thromb. Vasc. Biol. pmid:14764421
Kölsch H et al. Altered levels of plasma 24S- and 27-hydroxycholesterol in demented patients. 2004 Neurosci. Lett. pmid:15364416
Leoni V et al. Diagnostic use of cerebral and extracerebral oxysterols. 2004 Clin. Chem. Lab. Med. pmid:15061359
Burkard I et al. Determination of 24S- and 27-hydroxycholesterol in plasma by high-performance liquid chromatography-mass spectrometry. 2004 J. Lipid Res. pmid:14729854
Lütjohann D et al. High doses of simvastatin, pravastatin, and cholesterol reduce brain cholesterol synthesis in guinea pigs. 2004 Steroids pmid:15219793
Brown J et al. Differential expression of cholesterol hydroxylases in Alzheimer's disease. 2004 J. Biol. Chem. pmid:15148325
Heverin M et al. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. 2004 J. Lipid Res. pmid:14523054
Reiss AB et al. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. 2004 Neurobiol. Aging pmid:15212822
Vega GL et al. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins. 2004 Curr Alzheimer Res pmid:15975088
Teunissen CE et al. Serum cholesterol, precursors and metabolites and cognitive performance in an aging population. 2003 Jan-Feb Neurobiol. Aging pmid:12493560
Vega GL et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. 2003 Arch. Neurol. pmid:12707064
Kölsch H et al. The role of 24S-hydroxycholesterol in Alzheimer's disease. 2003 J Nutr Health Aging pmid:12679839
Leoni V et al. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. 2003 J. Lipid Res. pmid:12562838